BioLineRx (BLRX) Other Gross PP&E Adjustments (2023 - 2025)
Historic Other Gross PP&E Adjustments for BioLineRx (BLRX) over the last 3 years, with Q3 2025 value amounting to -$724000.0.
- BioLineRx's Other Gross PP&E Adjustments rose 4821.17% to -$724000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$724000.0, marking a year-over-year increase of 4821.17%. This contributed to the annual value of -$967000.0 for FY2024, which is 3166.08% up from last year.
- Per BioLineRx's latest filing, its Other Gross PP&E Adjustments stood at -$724000.0 for Q3 2025, which was up 4821.17% from -$800000.0 recorded in Q2 2025.
- In the past 5 years, BioLineRx's Other Gross PP&E Adjustments ranged from a high of -$724000.0 in Q3 2025 and a low of -$1.7 million during Q1 2023
- Moreover, its 3-year median value for Other Gross PP&E Adjustments was -$1.4 million (2024), whereas its average is -$1.2 million.
- Per our database at Business Quant, BioLineRx's Other Gross PP&E Adjustments skyrocketed by 437.76% in 2024 and then surged by 4821.17% in 2025.
- BioLineRx's Other Gross PP&E Adjustments (Quarter) stood at -$1.4 million in 2023, then skyrocketed by 31.66% to -$967000.0 in 2024, then grew by 25.13% to -$724000.0 in 2025.
- Its Other Gross PP&E Adjustments stands at -$724000.0 for Q3 2025, versus -$800000.0 for Q2 2025 and -$863000.0 for Q1 2025.